GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
| Revenue (TTM) | $21.27B |
| Gross Profit (TTM) | $8.41B |
| EBITDA | $3.59B |
| Operating Margin | 15.00% |
| Return on Equity | 19.40% |
| Return on Assets | 5.13% |
| Revenue/Share (TTM) | $46.79 |
| Book Value | $24.30 |
| Price-to-Book | 3.03 |
| Price-to-Sales (TTM) | 1.55 |
| EV/Revenue | 1.963 |
| EV/EBITDA | 11.30 |
| Quarterly Earnings Growth (YoY) | 16.80% |
| Quarterly Revenue Growth (YoY) | 5.80% |
| Shares Outstanding | $454.89M |
| Float | $450.25M |
| % Insiders | 0.36% |
| % Institutions | 92.00% |
Volatility is currently contracting
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now?
GE HealthCare (GEHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
GE HealthCare Technologies (GEHC) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GEHC broke through the 200-day moving average, which suggests a long-term bullish trend.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GE HealthCare Technologies (GEHC) is rated Buy, with risk-reward attractive due to accelerating growth and an undervalued multiple versus peers. Order growth, backlog expansion, and a robust innovation pipeline position GEHC for revenue acceleration and margin improvement as new products scale. Patient Care Solutions business is expected to recover as supply chain issues resolve, supporting overall growth and margin rebound.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
BENSALEM, Pa., July 31, 2026 /PRNewswire/ -- Law Offices of Howard G.
LOS ANGELES, July 31, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ:GEHC) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC.
LOS ANGELES, July 30, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ:GEHC) on behalf of investors concerning the Company's possible violations of federal securities laws.
BENSALEM, Pa., July 30, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company's possible violations of federal securities laws.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on GEHC and any ticker you trade — then tracks every position and per-strategy win rate.
